The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Open accessAbstract
BACKGROUND: Patients with arthritis and vascular disease may receive both low-dose aspirin and other nonsteroidal antiinflammatory drugs. We therefore investigated potential interactions between aspirin and commonly prescribed arthritis therapies METHODS: We administered the following combinations of drugs for six days: aspirin (81 mg every morning) two hours before ibuprofen (400 mg every morning) and the same medications in the reverse order; aspirin two hours before acetaminophen (1000 mg every morning) and the same medications in the reverse order; aspirin two hours before the cyclooxygenase-2 inhibitor rofecoxib (25 mg every morning) and the same medications in the reverse order; enteric-coated aspirin two hours before ibuprofen (400 mg three times a day); and enteric-coated aspirin two hours before delayed-release diclofenac (75 mg twice daily) RESULTS: Serum thromboxane B(2) levels (an index of cyclooxygenase-1 activity in platelets) and platelet aggregation were maximally inhibited 24 hours after the administration of aspirin on day 6 in the subjects who took aspirin before a single daily dose of any other drug, as well as in those who took rofecoxib or acetaminophen before taking aspirin. In contrast, inhibition of serum thromboxane B(2) formation and platelet aggregation by aspirin was blocked when a single daily dose of ibuprofen was given before aspirin, as well as when multiple daily doses of ibuprofen were given. The concomitant administration of rofecoxib, acetaminophen, or diclofenac did not affect the pharmacodynamics of aspirin CONCLUSIONS: The concomitant administration of ibuprofen but not rofecoxib, acetaminophen, or diclofenac antagonizes the irreversible platelet inhibition induced by aspirin. Treatment with ibuprofen in patients with increased cardiovascular risk may limit the cardioprotective effects of aspirin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It can also antagonize the platelet inhibition induced by low dose aspirin and lessens its cardioprotective effect (46).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bombardier, C., Laine, L., Reicin, A. S., Shapiro, D., Burgos‐Vargas, R., Davis, B. R., Day, R. O., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,014
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,572
Self-citationMcAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S. C., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,304
Self-citationThe X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
Picot, D., Loll, P. J., & Garavito, R. M. (1994) · Nature · doi:10.1038/367243a0 · Cited by 1,270
Patrono, C., Coller, B. S., Dalen, J. E., Gerald, G. A. F., Fuster, V., Gent, M., Hirsh, J., & Roth, G. J. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.39s · Cited by 961
Patrignani, P., Filabozzi, P., & Patrono, C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110576 · Cited by 931
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2
Luong, C., Miller, A. B., Barnett, J. W., Chow, J., Ramesha, C. S., & Browner, M. F. (1996) · Nature Structural Biology · doi:10.1038/nsb1196-927 · Cited by 620
Catella-Lawson, F., McAdam, B. F., Morrison, B. W., Kapoor, S. C., Kujubu, D. A., Antes, L. M., Lasseter, K. C., Quan, H., Gertz, B. J., & FitzGerald, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 596
Self-citation
Flagged first, then by citations
Research works printed but not linked: 7
- Singh G, 1999, J Rheumatol, 26, 18
- Patrignani P, 1999, J Physiol Pharmacol, 50, 661
- Pathmakanthan S, 1998, Ir Med J, 91, 58
- Patrignani P, 1994, J Pharmacol Exp Ther, 271, 1705
- Sciulli MG, Patrignani P, Seta F, et al. Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells in vitro. In: Proceedings of the 11th International Conference on Advances in Prostaglandin and Leukotriene Research: Basic Science and New Clinical Applications, Florence, Italy, June 4–8, 2000:38. abstract.
- Reilly IAG, 1987, Blood, 69, 180, 10.1182/blood.V69.1.180.180 · DOI
- Catella-Lawson F, 1999, J Pharmacol Exp Ther, 289, 735
Cited by
Sorted by citations
McCrindle, B. W., Rowley, A. H., Newburger, J. W., Burns, J. C., Bolger, A. F., Gewitz, M. H., Baker, A., Jackson, M. A., Takahashi, M., Shah, P. B., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000484 · Cited by 3,740
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
Ridker, P. M., Cook, N. R., Lee, I.-M., Gordon, D., Gaziano, J. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050613 · Cited by 1,945
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
Newburger, J. W., Takahashi, M., Gerber, M. A., Gewitz, M. H., Tani, L. Y., Burns, J. C., Shulman, S. T., Bolger, A. F., Ferrieri, P., Baltimore, R. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000145143.19711.78 · Cited by 1,928
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes
Bassand, J., Hamm, C. W., Ardissino, D., Boersma, E. H., Budaj, A., Fernández‐Avilés, F., Fox, K. A. A., Hasdai, D., Ohman, E. M., Wallentin, L. C., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm161 · Cited by 1,860
Antithrombotic Therapy in Neonates and Children
Monagle, P., Chan, A. K. C., Goldenberg, N. A., Ichord, R., Journeycake, J. M., Nowak‐Göttl, U., & Vesely, S. K. (2012) · CHEST Journal · doi:10.1378/chest.11-2308 · Cited by 1,486
Newburger, J. W., Takahashi, M., Gerber, M. A., Gewitz, M. H., Tani, L. Y., Burns, J. C., Shulman, S. T., Bolger, A. F., Ferrieri, P., Baltimore, R. S., et al. (2004) · PEDIATRICS · doi:10.1542/peds.2004-2182 · Cited by 1,426
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Pfisterer, M. E., Rocca, H. B., Buser, P. T., Rickenbacher, P. R., Hunziker, P., Mueller, C. E., Jeger, R. V., Bader, F., Osswald, S., & Kaiser, C. A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.026 · Cited by 1,303
Low-Dose Aspirin for the Prevention of Atherothrombosis
Patrono, C., Rodríguez, L. A. G., Landolfi, R., & Baigent, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra052717 · Cited by 1,223
Cardiovascular Risk and Inhibition of Cyclooxygenase
McGettigan, P., & Henry, D. A. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60011 · Cited by 1,106
Großer, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,031
Patrono, C., Coller, B. S., Dalen, J. E., Gerald, G. A. F., Fuster, V., Gent, M., Hirsh, J., & Roth, G. J. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.39s · Cited by 961
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
Nissen, S. E., Yeomans, N. D., Solomon, D. H., Lüscher, T. F., Libby, P., Husni, M. E., Graham, D. Y., BORER, J. S., Wisniewski, L. M., Wolski, K. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1611593 · Cited by 867
Antman, E. M., Bennett, J. S., Daugherty, A., Furberg, C., Roberts, H., & Taubert, K. A. (2007) · Circulation · doi:10.1161/circulationaha.106.181424 · Cited by 804
Ferriero, D. M., Fullerton, H. J., Bernard, T. J., Billinghurst, L. L., Daniels, S. R., DeBaun, M. R., deVeber, G., Ichord, R., Jordan, L. C., Massicotte, P. M., et al. (2019) · Stroke · doi:10.1161/str.0000000000000183 · Cited by 803
Patrono, C., Baigent, C., Hirsh, J., & Roth, G. J. (2008) · CHEST Journal · doi:10.1378/chest.08-0672 · Cited by 751
Platelets at the interface of thrombosis, inflammation, and cancer
Franco, A. T., Corken, A. L., & Ware, J. L. (2015) · Blood · doi:10.1182/blood-2014-08-531582 · Cited by 711
Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation
Lau, W. C., Waskell, L. A., Watkins, P. B., Neer, C. J., Horowitz, K., Hopp, A. S., Tait, A. R., Carville, D. G. M., Guyer, K. E., & Bates, E. (2003) · Circulation · doi:10.1161/01.cir.0000047060.60595.cc · Cited by 686
Antithrombotic Therapy in Neonates and Children
Monagle, P., Chalmers, E. A., Chan, A. K. C., deVeber, G., Kirkham, F. J., Massicotte, P. M., & Michelson, A. D. (2008) · CHEST Journal · doi:10.1378/chest.08-0762 · Cited by 673
Graham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
Ibuprofen: pharmacology, efficacy and safety
Rainsford, K. D. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-0016-x · Cited by 699
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
Patrono, C., Coller, B. S., FitzGerald, G. A., Hirsh, J., & Roth, G. J. (2004) · CHEST Journal · doi:10.1378/chest.126.3_suppl.234s · Cited by 670
Self-citationParacetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 674
A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics
Mutua, V. N., & Gershwin, L. J. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08804-7 · Cited by 662
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
Warner, T. D., & Mitchell, J. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0645rev · Cited by 617
Rapezzi, C., Biagini, E., & Branzi, A. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm498 · Cited by 593
An Evidence-Based Update on Nonsteroidal Anti-Inflammatory Drugs
Ong, C. K. S., Lirk, P. B., Tan, C.-W., & Seymour, R. A. (2007) · Clinical Medicine & Research · doi:10.3121/cmr.2007.698 · Cited by 599
McGettigan, P., & Henry, D. A. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001098 · Cited by 579
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
Kimura, K., Kimura, T., Ishihara, M., Nakagawa, Y., Nakao, K., Miyauchi, K., Sakamoto, T., Tsujita, K., Hagiwara, N., Miyazaki, S., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0133 · Cited by 565
Weitz, J. I., Eikelboom, J. W., & Samama, M. M. (2012) · CHEST Journal · doi:10.1378/chest.11-2294 · Cited by 539
Hankey, G. J., & Eikelboom, J. W. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68040-9 · Cited by 543
Gogarten, W., Vandermeulen, E., Aken, H. V., Kozek, S. A., Llau, J. V., & Samama, C. M. (2010) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32833f6f6f · Cited by 527
Corley, D. A., Kerlikowske, K. M., Verma, R., & Buffler, P. A. (2003) · Gastroenterology · doi:10.1053/gast.2003.50008 · Cited by 524
Cannon, C. P., Curtis, S., FitzGerald, G. A., Krum, H., Kaur, A., Bolognese, J. A., Reicin, A. S., Bombardier, C., Weinblatt, M. E., van der Heijde, D. M. F. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69666-9 · Cited by 533
Self-citationCOX-2 and beyond: approaches to prostaglandin inhibition in human disease
FitzGerald, G. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1225 · Cited by 518
Self-citationNeutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases
Wigerblad, G., & Kaplan, M. J. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00787-0 · Cited by 533
Rabbani, G., & Ahn, S. N. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.053 · Cited by 512
Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology
Altman, R. D., Bosch, B., Brune, K., Patrignani, P., & Young, C. L. (2015) · Drugs · doi:10.1007/s40265-015-0392-z · Cited by 494
Farkouh, M. E., Kirshner, H. S., Harrington, R. A., Ruland, S. D., Verheugt, F. W. A., Schnitzer, T. J., Burmester, G. R., Mysler, E., Hochberg, M. C., Doherty, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16894-3 · Cited by 490
Lau, W. C., Gurbel, P. A., Watkins, P. B., Neer, C. J., Hopp, A. S., Carville, D. G. M., Guyer, K. E., Tait, A. R., & Bates, E. (2004) · Circulation · doi:10.1161/01.cir.0000112378.09325.f9 · Cited by 487
Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man
Hinz, B., Cheremina, O., & Brune, K. (2008) · The FASEB Journal · doi:10.1096/fj.07-8506com · Cited by 478
New insights into the use of currently available non-steroidal anti-inflammatory drugs
Brune, & Patrignani, P. (2015) · Journal of Pain Research · doi:10.2147/jpr.s75160 · Cited by 498
Perioperative Management of Antithrombotic Therapy
Douketis, J. D., Spyropoulos, A. C., Murad, M. H., Arcelus, J. I., Dager, W. E., Dunn, A. S., Fargo, R. A., Levy, J. H., Samama, C. M., Shah, S. H., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.07.025 · Cited by 494
Gislason, G., Jacobsen, S., Rasmussen, J. N., Rasmussen, S., Buch, P., Friberg, J., Schramm, T. K., Abildstrom, S. Z., Køber, L., Madsen, M., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.616219 · Cited by 446
Effect of ibuprofen on cardioprotective effect of aspirin
MacDonald, T. M., & Li, W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12509-3 · Cited by 419
Snoep, J. D. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1593 · Cited by 418
Cattaneo, M. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000145980.39477.a9 · Cited by 412
Conaghan, P. G. (2011) · Rheumatology International · doi:10.1007/s00296-011-2263-6 · Cited by 420
Patrono, C. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.10.013 · Cited by 408
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease
Giglia, T. M., Massicotte, M. P., Tweddell, J. S., Barst, R. J., Bauman, M. E., Erickson, C. C., Feltes, T. F., Foster, E., Hinoki, K., Ichord, R., et al. (2013) · Circulation · doi:10.1161/01.cir.0000436140.77832.7a · Cited by 400
Mazaleuskaya, L. L., Sangkuhl, K., Thorn, C. F., FitzGerald, G. A., Altman, R. B., & Klein, T. E. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000150 · Cited by 381
Self-citationEikelboom, J. W., Hirsh, J., Spencer, F. A., Baglin, T. P., & Weitz, J. I. (2012) · CHEST Journal · doi:10.1378/chest.11-2293 · Cited by 389
Anti-inflammatory effects of aspirin and sodium salicylate
Amann, R., & Peskar, B. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01828-9 · Cited by 376
Nonsteroidal Anti-Inflammatory Drugs: Adverse Effects and Their Prevention
Vonkeman, H. E., & van de Laar, M. A. F. J. (2008) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.08.001 · Cited by 379
Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications
Narouze, S., Benzon, H. T., Provenzano, D. A., Buvanendran, A., Andrés, J. A. D., Deer, T. R., Rauck, R. L., & Huntoon, M. A. (2015) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0000000000000223 · Cited by 366
Chen, Y., Jobanputra, P., Barton, P. M., Bryan, S., Fry-Smith, A., Harris, G., & Taylor, R. (2008) · Health Technology Assessment · doi:10.3310/hta12110 · Cited by 343
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function
Cheng, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27540 · Cited by 339
COX-2 Inhibitors and Cardiovascular Risk
Funk, C. D., & FitzGerald, G. A. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318157f72d · Cited by 333
Self-citationComprehensive review of cardiovascular toxicity of drugs and related agents
Mladěnka, P., Applová, L., Patočka, J., Costa, V. M., Remião, F., Pourová, J., Mladěnka, A., Karlíčková, J., Jahodář, L., Vopršalová, M., et al. (2018) · Medicinal Research Reviews · doi:10.1002/med.21476 · Cited by 340
Towards a mechanism-based approach to pain management in osteoarthritis
Malfait, A., & Schnitzer, T. J. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.138 · Cited by 324
Aspirin and clopidogrel resistance: an emerging clinical entity
Wang, T. H., Bhatt, D. L., & Topol, E. J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi684 · Cited by 308
Hypertension in rheumatoid arthritis
Panoulas, V. F., Metsios, G. S., Pace, A. V., John, H., Treharne, G. J., Banks, M., & Kitas, G. D. (2008) · Rheumatology · doi:10.1093/rheumatology/ken159 · Cited by 309
Rodríguez, L. A. G., Tacconelli, S., & Patrignani, P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.041 · Cited by 303
Aspirin resistance: definition, mechanisms and clinical read-outs
Patrono, C. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00284.x · Cited by 298
Gislason, G., Rasmussen, J. N., Abildstrom, S. Z., Schramm, T. K., Hansen, M. L., Fosbøl, E. L., Sørensen, R., Folke, F., Buch, P., Gadsbøll, N., et al. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.525 · Cited by 295
Cyclooxygenase Inhibition and Cardiovascular Risk
Antman, E. M., DeMets, D. L., & Loscalzo, J. (2005) · Circulation · doi:10.1161/circulationaha.105.568451 · Cited by 285
Li, J., Kuang, Y., Gao, Y., Du, X., Shi, J., & Xu, B. (2012) · Journal of the American Chemical Society · doi:10.1021/ja310019x · Cited by 283
Mamdani, M., Rochon, P. A., Juurlink, D. N., Anderson, G., Kopp, A., Naglie, G., Austin, P. C., & Laupacis, A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.481 · Cited by 281
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects
Capone, M. L., Sciulli, M. G., Tacconelli, S., Grana, M., Ricciotti, E., Renda, G., Gregorio, P. D., Merciaro, G., & Patrignani, P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.045 · Cited by 280
Santilli, F., Rocca, B., CRISTOFARO, R. D., Lattanzio, S., Pietrangelo, L., Habib, A., Pettinella, C., Recchiuti, A., Ferrante, E., Ciabattoni, G., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.047 · Cited by 266
Pharmacodynamic Drug–Drug Interactions
Niu, J., Straubinger, R. M., & Mager, D. E. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1434 · Cited by 278
Kurth, T., Glynn, R. J., Walker, A. M., Chan, K. A., Buring, J. E., Hennekens, C. H., & Gaziano, J. M. (2003) · Circulation · doi:10.1161/01.cir.0000087593.07533.9b · Cited by 254
Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions
Undas, A., Brummel‐Ziedins, K. E., & Mann, K. G. (2006) · Blood · doi:10.1182/blood-2006-01-010645 · Cited by 253
Laine, L., Curtis, S., Cryer, B., Kaur, A., & Cannon, C. P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60234-7 · Cited by 248
Gastrointestinal Safety of Cyclooxygenase-2 Inhibitors: A Cochrane Collaboration Systematic Review
Rostom, A., Muir, K. E., Dubé, C., Jolicoeur, E., Boucher, M., Joyce, J. L., Tugwell, P., & Wells, G. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.03.011 · Cited by 242
Fuster, V., & Sweeny, J. M. (2011) · Circulation · doi:10.1161/circulationaha.110.963843 · Cited by 254
Cyclooxygenase inhibitors: From pharmacology to clinical read-outs
Patrignani, P., & Patrono, C. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.016 · Cited by 244
Antiplatelet agents for the treatment and prevention of atherothrombosis
Patrono, C., Andreotti, F., Arnesen, H., Badimón, L., Baigent, C., Collet, J., Caterina, R. D., Gulba, D. C., Huber, K., Husted, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr373 · Cited by 239
For the International NSAID Consensus Group, Scarpignato, C., Lanas, Á., Blandizzi, C., Lems, W. F., Hermann, M., & Hunt, R. H. (2015) · BMC Medicine · doi:10.1186/s12916-015-0285-8 · Cited by 256
Kuliczkowski, W., Witkowski, A., Poloński, L., Watała, C. W., Filipiak, K. J., Budaj, A., Golański, J., Sitkiewicz, D., Pręgowski, J., Górski, J., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn562 · Cited by 234
Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets
Samad, T. A., Sapirstein, A., & Woolf, C. J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02383-3 · Cited by 229
Yang, F., Bian, C., Zhu, L., Zhao, G., Huang, Z., & Huang, M. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.08.015 · Cited by 228
Platelet Response to Low-Dose Enteric-Coated Aspirin in Patients With Stable Cardiovascular Disease
Maree, A. O., Curtin, R. J., Dooley, M., Conroy, R. M., Crean, P., Cox, D. M., & Fitzgerald, D. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.058 · Cited by 225
Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks
Meek, I., van de Laar, M. A. F. J., & Vonkeman, H. E. (2010) · Pharmaceuticals · doi:10.3390/ph3072146 · Cited by 232
ARONOFF, D., OATES, J., & BOUTAUD, O. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.09.009 · Cited by 222
Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General Population
Rodríguez, L. A. G., Varas‐Lorenzo, C., Maguire, A., & González‐Pérez, A. (2004) · Circulation · doi:10.1161/01.cir.0000132491.96623.04 · Cited by 221
Critical Reviews in Clinical Laboratory Sciences
Linden, M. D., & Tran, H. A. (2012) · Cited by 217
Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion
Wong, R. S.-Y. (2019) · Advances in Pharmacological Sciences · doi:10.1155/2019/3418975 · Cited by 223
Massive hemoptysis in cystic fibrosis
Flume, P. A., Yankaskas, J. R., Ebeling, M., Hulsey, T., & Clark, L. L. (2005) · Chest · doi:10.1378/chest.128.2.729 · Cited by 215
Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs
Cooney, N., Pollack, C. V., & Butkerait, P. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s79135 · Cited by 214
Variable Platelet Response to Aspirin and Clopidogrel in Atherothrombotic Disease
Maree, A. O., & Fitzgerald, D. J. (2007) · Circulation · doi:10.1161/circulationaha.106.675991 · Cited by 213
Boutaud, O., Aronoff, D. M., Richardson, J. H., Marnett, L. J., & Oates, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102588199 · Cited by 209
Aspirin Resistance and Atherothrombotic Disease
Mason, P. J., Jacobs, A. K., & Freedman, J. E. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.070 · Cited by 209
Drug Resistance and Pseudoresistance
Großer, T., Fries, S., Lawson, J. A., Kapoor, S. C., Grant, G. R., & FitzGerald, G. A. (2012) · Circulation · doi:10.1161/circulationaha.112.117283 · Cited by 208
Self-citationCoxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1
Rimon, G., Sidhu, R. S., Lauver, A. A., Lee, J. Y., Sharma, N. P., Yuan, C., Frieler, R. A., Trievel, R. C., Lucchesi, B. R., & Smith, W. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909765106 · Cited by 208
Hall, R., & Mazer, C. D. (2011) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318203f38d · Cited by 203
Nonsteroidal anti-inflammatory drugs in cats: a review
Lascelles, B. D. X., Court, M. H., Hardie, E. M., & Robertson, S. A. (2007) · Veterinary Anaesthesia and Analgesia · doi:10.1111/j.1467-2995.2006.00322.x · Cited by 202
Non‐Steroidal Antiinflammatory Drugs and the Risk of Acute Myocardial Infarction
Hernández–Dı́az, S., Varas‐Lorenzo, C., & Rodríguez, L. A. G. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_302.x · Cited by 201
Charlot, M. G., Grove, E. L., Hansen, P. R., Olesen, J. B., Ahlehoff, O., Selmer, C., Lindhardsen, J., Madsen, J. K., Køber, L., Torp-Pedersen, C. T., et al. (2011) · BMJ · doi:10.1136/bmj.d2690 · Cited by 200
Twine, C. P., Kakkos, S. K., Aboyans, V., Baumgärtner, I., Behrendt, C., Bellmunt-Montoya, S., Jilma, B., Nordanstig, J., Saratzis, A. N., Reekers, J. A., et al. (2023) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2023.03.042 · Cited by 212
Metadata
- Authors
- Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A.
- Affiliations
- University of Pennsylvania (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-12-20
- Volume
- 345
- Issue
- 25
- Pages
- 1809-1817
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2011327495
- Cited by
- 1,394
- References
- 44
- Citations by year
- 2026: 19 · 2025: 15 · 2024: 18 · 2023: 18 · 2022: 33 · 2021: 43 · 2020: 33 · 2019: 40 · 2018: 40 · 2017: 46 · 2016: 41 · 2015: 56 · 2014: 46 · 2013: 69 · 2012: 79
- FWCI
- 50.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 5400, HL62250, P01HL062250)
- National Center for Research Resources (M01-RR-00040, M01RR000040)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- aspirin, ibuprofen, cyclooxygenase inhibitors, rofecoxib, diclofenac, paracetamol, drug interactions, platelet aggregation, thromboxane B2, antiplatelet activity, nonsteroidal anti-inflammatory drugs, arthritis treatment, cardiovascular risk, cardioprotection
- MeSH terms
- Acetaminophen, Adult, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Diclofenac, Drug Interactions, Drug Therapy, Combination, Humans, Ibuprofen, Isoenzymes, Lactones, Membrane Proteins, Middle Aged, Platelet Aggregation, Platelet Aggregation Inhibitors, Prostaglandin-Endoperoxide Synthases, Sulfones, Thromboxane B2, Dinoprostone, Cyclooxygenase Inhibitors, Cross-Over Studies, Analgesics, Non-Narcotic, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
